Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents

Abstract

able for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The corresponding author, M.W., had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.